SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-24-003698
Filing Date
2024-05-20
Accepted
2024-05-20 17:03:23
Documents
18

Document Format Files

Seq Description Document Type Size
1 FORM S-3 phio_s3.htm   iXBRL S-3 323314
2 OPINION OF HOGAN LOVELLS US LLP phio_ex0501.htm EX-5.1 19308
3 CONSENT OF BDO USA, P.C., AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2328
4 CALCULATION OF FILING FEE TABLES phio_ex107.htm EX-FILING FEES 94905
5 GRAPHIC image_002.jpg GRAPHIC 4819
6 GRAPHIC image_001.jpg GRAPHIC 3828
  Complete submission text file 0001683168-24-003698.txt   692787

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE phio-20240520.xsd EX-101.SCH 3021
8 XBRL LABEL FILE phio-20240520_lab.xml EX-101.LAB 34767
9 XBRL PRESENTATION FILE phio-20240520_pre.xml EX-101.PRE 22721
21 EXTRACTED XBRL INSTANCE DOCUMENT phio_s3_htm.xml XML 3303
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279557 | Film No.: 24965533
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)